Taken together, our results suggest that PaCa-induced NETs can contribute to the high risk of venous thromboembolism development in PaCa patients, and reveal NETs as a potential therapeutic target. This evidence concerns the gene PTF1A and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.